General Counsel Jeff Cislini News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from General counsel jeff cislini. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In General Counsel Jeff Cislini Today - Breaking & Trending Today

Bellevue Group AG Boosts Stock Holdings in Revolution Medicines, Inc. (NASDAQ:RVMD)

Bellevue Group AG boosted its position in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 7.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,091,000 shares of the company’s stock after purchasing an additional 369,500 shares during the period. Revolution Medicines […] ....

Jack Anders , Raymond James , Jeff Cislini , Piper Sandler , Bellevue Group , Revolution Medicines Inc , Exchange Commission , Securities Exchange Commission , Bain Capital Life Sciences Investors , Rafferty Asset Management , Investment Management , Revolution Medicines , Free Report , Fire Capital , Point Capital , Capital Life Sciences Investors , Asset Management , Medicines Stock Down , Get Free Report , General Counsel Jeff Cislini , Visit Holdingschannel , Revolution Medicines Daily ,

Bain Capital Life Sciences Investors LLC Takes Position in Revolution Medicines, Inc. (NASDAQ:RVMD)

Bain Capital Life Sciences Investors LLC bought a new stake in shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) during the 4th quarter, according to its most recent filing with the SEC. The firm bought 1,112,396 shares of the company’s stock, valued at approximately $31,904,000. Revolution Medicines accounts for 3.1% of Bain Capital Life […] ....

Jack Anders , Piper Sandler , Raymond James , Jeff Cislini , Clear Harbor Asset Management , Securities Exchange Commission , Needham Company , Hermes Inc , Bain Capital Life Sciences Investors , Fred Alger Management , Mackenzie Financial Corp , Manchester Capital Management , Revolution Medicines Inc , Revolution Medicines , Free Report , Capital Life Sciences Investors , Capital Management , Alger Management , Harbor Asset Management , General Counsel Jeff Cislini , Exchange Commission , Get Free Report , Visit Holdingschannel , Revolution Medicines Daily ,

Revolution Medicines, Inc. (NASDAQ:RVMD) Receives $43.20 Average Target Price from Brokerages

Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) has been given an average rating of “Buy” by the ten analysts that are currently covering the firm, MarketBeat reports. Nine investment analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year target […] ....

Piper Sandler , Jeff Cislini , Sushil Patel , Raymond James , Revolution Medicines Inc , Janus Henderson Group , Securities Exchange Commission , Revolution Medicines Company Profile , Needham Company , Paloma Partners Management Co , Farallon Capital Management , Revolution Medicines , Get Free Report , Medicines Trading Down , General Counsel Jeff Cislini , Exchange Commission , Director Sushil Patel , Capital Management , Henderson Group , Get Free , Revolution Medicines Daily ,

Revolution Medicines (NASDAQ:RVMD) Sets New 52-Week High at $40.63

Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) reached a new 52-week high during trading on Wednesday . The company traded as high as $40.63 and last traded at $40.05, with a volume of 295845 shares trading hands. The stock had previously closed at $39.66. Analyst Upgrades and Downgrades Several research analysts have issued reports […] ....

United States , Raymond James , Jack Anders , Jeff Cislini , Piper Sandler , Needham Company , Revolution Medicines Inc , Proshare Advisors , Swiss National Bank , Headlands Technologies , Securities Exchange Commission , Revolution Medicines Company Profile , Revolution Medicines , Get Free Report , Medicines Trading Down , General Counsel Jeff Cislini , Exchange Commission , Retirement System , National Bank , Share Advisors , Revolution Medicines Daily ,

Wedbush Boosts Revolution Medicines (NASDAQ:RVMD) Price Target to $46.00

Wedbush Boosts Revolution Medicines (NASDAQ:RVMD) Price Target to $46.00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Piper Sandler , Raymond James , Jeff Cislini , Jack Anders , China Universal Asset Management Co , Needham Company , Headlands Technologies , Revolution Medicines Inc , Securities Exchange Commission , Swiss National Bank , Revolution Medicines , Free Report , Get Free Report , General Counsel Jeff Cislini , Exchange Commission , Retirement System , Universal Asset Management , National Bank , Revolution Medicines Daily ,